Pregnancy on Oral Glucose Tolerance Test Implementation Status, Knowledge, and Anxiety Level

NCT05686694 | Completed

• 2 other identifiers: EGE-OZLEM-35Gülcan KARABULUT
• Study Type: interventional
• Target: 114
• Locations: 1 country
• Sites: 1

Brief Summary

This study was planned to examine the effect of video education on pregnancy for oral glucose tolerance test implementation status, knowledge and anxiety level. The research was planned as a single-blind randomized controlled experimental study.

Conditions

Gestational Diabetes

Keywords

Oral Glucose Tolerance Test; Primiparous Pregnant; Knowledge Level; Anxiety; Nursing

Outcome Measures

Primary Outcomes (2)

• Knowledge Level Form on the Pregnancy Diabetes and Oral Glucose Tolerance Test

  Pregnant women will respond to each information sentence by choosing one of the options "True", "False", "I don't know". It is planned that the form will consist of 25 or 30 items. The state of knowing the items before and after the education will be evaluated with a percentage.

  before 24. pregnancy weeks and 30-34. pregnancy weeks

• State Anxiety Scale

  During the evaluation, a score between 1 (or -1) and 4 (or -4) is given for each item according to the positive or negative feature of the item, and the constant 50 is added to the total score to be obtained. The highest score is 80 and the lowest score is 20. The higher the total anxiety score, the higher the anxiety level of the person completing the inventory.

  24-28. pregnancy weeks

Study Arms (2)

Education Group

EXPERIMENTAL

1. Follow-up (\<24 weeks): "Questionnaire for Descriptive Characteristics of Pregnants" and "Informed Consent Form" and pretest application "Knowledge Level Form on the Pregnancy Diabetes and Oral Glucose Tolerance Test" will be made. 2. Follow-up (\<24. Week): Watching education videos:the education will end in 3 weeks. After that,post-test application "Knowledge Level Form on the Pregnancy Diabetes and Oral Glucose Tolerance Test" will be applied. They will be asked about their intention to have an OGTT. 3. Follow-up (24-28. weeks): (Waiting after 75 mg dose is administered during OGTT): "State Anxiety Scale" will be applied. The OGTT implementation status of the pregnant woman will be recorded. 4. Follow-up (30-34. weeks): 6 weeks after the video education, the "Knowledge Level Form on the Pregnancy Diabetes and Oral Glucose Tolerance Test" post-test application will be made.

Other: Video Education

Control Group

NO INTERVENTION

1. Follow-up (\<24 weeks): "Questionnaire for the Introductory Characteristics of Pregnants" and "Informed Consent Form", and pre-test application "Knowledge Level Form on the Pregnancy Diabetes and Oral Glucose Tolerance Test" will be made. 2. Follow-up (before OGTT implementation at 24-28 weeks): A posttest application will be made"Knowledge Level Form on Pregnancy Diabetes and Oral Glucose Tolerance Test". It will be asked about their intention to have an OGTT. 3. Follow-up (24-28. weeks) (Waiting after 75 mg dose is administered during OGTT):"State Anxiety Scale" will be applied face-to-face while the pregnant woman is waiting after 75 mg dose is administered during the OGTT application while she is with the pregnant woman on the test day. In addition, the OGTT implementation status of the pregnant woman will be recorded. 4. Follow-up (30-34 weeks): The post-test application of the "Knowledge Level Form on Pregnancy Diabetes and Oral Glucose Tolerance Test" will be made.

Interventions

Video Education OTHER

Sharing of Planned Education Videos on Instagram In this research, the platform where planned video education will be shared was determined as "Instagram", which is the most used social media platform by pregnant women. In the Instagram user name "@ogttegitim" account, 6 education videos that will be created and shared.

Education Group

Eligibility Criteria

• Age: 18 Years - 35 Years
• Gender Eligibility Details: Female
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• Reading and understanding Turkish
• literate
• over 18 years old
• under 35 years old
• primiparous pregnant
• before 24 weeks of pregnancy
• having a computer or phone and able to access the internet
• using Instagram
• voluntarily agreed to participate in the study

You may not qualify if:

• have a diagnosis of chronic diabetes mellitus (DM)
• have an ectopic pregnancy,
• want to leave the study voluntarily,
• in the education group but do not watch all the education videos
• have miscarriage or preterm birth
• pregnant women who do not fill in the all forms in study
• cannot be contacted during the research
• who decide to continue their doctor's checkups in another hospital

Sponsors & Collaborators

• Ege University: lead

Study Sites (1)

Sağlık Bilimleri Üniversitesi Sarıyer Hamidiye Etfal Eğitim ve Araştırma Hastanesi

Istanbul, 34453, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Diabetes, Gestational; Anxiety Disorders

Condition Hierarchy (Ancestors)

Pregnancy Complications; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Diabetes Mellitus; Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Endocrine System Diseases; Mental Disorders

Study Officials

• Özlem Demirel Bozkurt, Assoc. Prof.

  Ege University Nursing Faculty

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Masking Details: The research was planned as a single-blind randomized controlled experimental study. The homogeneity of the pregnant women in the education and control groups will be ensured according to age, education level and Instagram usage time. Considering the inclusion and exclusion criteria of the study, pregnant women will be divided into education and control groups by stratified randomization method. For this purpose, pregnant women who meet the criteria of the study will be assigned to the education and control group using a computer-assisted randomization program (https://www.random.org/). Pregnant women will not be informed about the groups they are in, and only the researcher will know which group they will be in, and single-blindness will be provided.
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assoc. Prof.

Model Details: single-blind, randomized controlled, experimental design

Study Record Dates

• First Submitted: December 21, 2022
• First Posted: January 17, 2023
• Study Start: June 15, 2023
• Primary Completion: November 15, 2023
• Study Completion: April 22, 2024
• Last Updated: August 12, 2025

Record last verified: 2025-02

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)